Skip to main content

Actavis Lawsuits: First Work-Up Group Formed For 2019 Trial

Actavis Lawsuits: First Work-Up Group Formed For 2019 Trial

Actavis Lawsuits: First Work-Up Group Formed For 2019 Trial

Introduction

Testosterone Replacement Therapy lawsuits are centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois for coordinated discovery and management, as part of a federal multidistrict litigation (MDL) 2545 (In re: Testosterone Replacement Therapy Products Liability Litigation). It comprises more than 6,500 TRT lawsuits filed against AbbVie, Actavis, Inc. (formerly Watson Pharmaceuticals), Eli Lilly and Company, Teva Pharmaceuticals, Pharmacia & Upjohn Company, Endo Pharmaceuticals, Columbia Laboratories, and Auxilium Pharmaceuticals.

Allegations include severe side-effects linked to TRT, such as heart attacks, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and other serious medical conditions.

Judge Kennelly issued a case management order (PDF) on April 10, identifying the first Actavis Work-Up Group to be ready for trial early next year. The group comprises 30 Androderm cases selected by both the parties which are to be prepared for February and March 2019 jury trials. The judge ordered that the selection of the second group of work-up cases is to be completed by May 15, and the third group by June 29, 2018.

Auxilium and Eli Lilly, the manufacturers of Testim and Axiron are working on finalizing settlements that will help in resolving more than 1,500 lawsuits involving their products.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!